|
|
Targeted in vivo perturbation for dissecting tissue immune responses |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Clinical Core |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Project 2: T Cell Costimulation: Induction and Regulation of Autoimmunity |
| 5P01AI056299-19 |
|
NIAID |
2022 |
|
|
Project 3 - Mechanisms of DNRAb-mediated damage to the fetal brain |
| 5P01AI073693-13 |
|
NIAID |
2022 |
|
|
Innate Immune Response to S. aureus Biofilm |
| 5P01AI083211-14 |
|
NIAID |
2022 |
|
|
UC San Diego RAPID Faculty Development Program in Infectious Diseases |
| 5R25AI147376-03 |
|
NIAID |
2022 |
|
|
University of Pennsylvania Clinical Autoimmunity Center of Excellence |
| 5UM1AI144288-04 |
|
NIAID |
2022 |
|
|
Exploring the therapeutic mechanisms of proinflammatory myelin-laden macrophages retention in the injured spinal lesion core |
| 1R01NS126468-01 |
|
NINDS |
2022 |
|
|
Neurodevelopmental Function of TBC1D7: A Core Component of the TSC Complex |
| 1R21NS126952-01A1 |
|
NINDS |
2022 |
|
|
Clinical Trial Readiness for Multiple System Atrophy - Resubmission - 1 |
| 1U01NS122419-01A1 |
|
NINDS |
2022 |